Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Lotem

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Oncogene|May 29, 2002
Cytokine control of developmental programs in normal hematopoiesis and leukemiaJoseph Lotem, Leo Sachs
Seminars in Cancer Biology|August 23, 2002
Epigenetics wins over genetics: induction of differentiation in tumor cellsJoseph Lotem, Leo Sachs
The International Journal of Developmental Biology|June 17, 2017
The Leo Sachs' legacy: a pioneer's journey through hematopoiesisJoseph Lotem, Yoram Groner
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Carcinogen-induced skin tumor development requires leukocytic expression of the transcription factor Runx3Omri Bauer, Shay Hantisteanu, Joseph Lotem, et al.
Methods in Enzymology|March 30, 2004
p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1Gad Asher, Joseph Lotem, Leo Sachs, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2005
Human cancers overexpress genes that are specific to a variety of normal human tissuesJoseph Lotem, Dvir Netanely, Eytan Domany, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2002
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1Gad Asher, Joseph Lotem, Leo Sachs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
NQO1 stabilizes p53 through a distinct pathwayGad Asher, Joseph Lotem, Rachel Kama, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Induction in myeloid leukemic cells of genes that are expressed in different normal tissuesJoseph Lotem, Hila Benjamin, Dvir Netanely, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2008
A regulatory interplay between miR-27a and Runx1 during megakaryopoiesisOren Ben-Ami, Niv Pencovich, Joseph Lotem, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Oncogene|May 29, 2002
Cytokine control of developmental programs in normal hematopoiesis and leukemiaJoseph Lotem, Leo Sachs
Seminars in Cancer Biology|August 23, 2002
Epigenetics wins over genetics: induction of differentiation in tumor cellsJoseph Lotem, Leo Sachs
The International Journal of Developmental Biology|June 17, 2017
The Leo Sachs' legacy: a pioneer's journey through hematopoiesisJoseph Lotem, Yoram Groner
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Carcinogen-induced skin tumor development requires leukocytic expression of the transcription factor Runx3Omri Bauer, Shay Hantisteanu, Joseph Lotem, et al.
Methods in Enzymology|March 30, 2004
p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1Gad Asher, Joseph Lotem, Leo Sachs, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2005
Human cancers overexpress genes that are specific to a variety of normal human tissuesJoseph Lotem, Dvir Netanely, Eytan Domany, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2002
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1Gad Asher, Joseph Lotem, Leo Sachs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
NQO1 stabilizes p53 through a distinct pathwayGad Asher, Joseph Lotem, Rachel Kama, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Induction in myeloid leukemic cells of genes that are expressed in different normal tissuesJoseph Lotem, Hila Benjamin, Dvir Netanely, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2008
A regulatory interplay between miR-27a and Runx1 during megakaryopoiesisOren Ben-Ami, Niv Pencovich, Joseph Lotem, et al.
Pageof 3